September 22, 2014 7:27 PM ET

Pharmaceuticals

Company Overview of Imarx Therapeutics, Inc.

Executive Profile

Andrei V. Alexandrov M.D.

Former Member of the Scientific Advisory Board, Imarx Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 1 different industries.

See Board Relationships
----

Background

Prof. Andrei V. Alexandrov, M.D serves as Professor, Director of Comprehensive Stroke Center and Director of Neurovascular Laboratory for Department of Neurology at University of Alabama. Prof. Alexandrov serves as Associate Professor and Director of Department of Neurology, Neurovascular Program at Houston Medical School, The University of Texas. Prof. Alexandrov serves as Chairman of Scientific Advisory Board at Cerevast Therapeutics, Inc. Prof. Alexandrov served as ...

Corporate Headquarters

12277 134th NE
Redmond, Washington 98052

United States

Phone: 425-821-5501
Fax: 425-821-1404

Board Members Memberships

There is no Board Members Memberships data available.

Education

There is no Education data available.

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Imarx Therapeutics, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.